AKTS
Akoustis Technologies Inc

3,049
Mkt Cap
$1.05B
Volume
236,612.00
52W High
$29.16
52W Low
$0.0372
Price
$20.00
AKTS Fundamentals
Prev Close
$19.43
Open
$19.54
50D MA
$19.29
Beta
0.00
Avg. Volume
494,614.31
EPS (Annual)
-$0.8374
P/B
-11.96
Loading...
Loading...
News
all
press releases
Aktis Oncology's Quiet Period Set To End on February 18th (NASDAQ:AKTS)
Aktis Oncology's (NASDAQ:AKTS - Get Free Report) quiet period is set to expire on Wednesday, February 18th. Aktis Oncology had issued 17,650,000 shares in its public offering on January 9th. The...
MarketBeat·14d ago
News Placeholder
More News
News Placeholder
Aktis Oncology (NASDAQ:AKTS) Coverage Initiated at TD Cowen
TD Cowen started coverage on shares of Aktis Oncology in a report on Tuesday. They issued a "buy" rating for the company...
MarketBeat·22d ago
News Placeholder
Aktis Oncology (NASDAQ:AKTS) Now Covered by Bank of America
Bank of America began coverage on Aktis Oncology in a research report on Tuesday. They issued a "buy" rating and a $34.00 price target on the stock...
MarketBeat·22d ago
News Placeholder
Aktis Oncology (NASDAQ:AKTS) Now Covered by Analysts at JPMorgan Chase & Co.
JPMorgan Chase & Co. began coverage on Aktis Oncology in a research note on Tuesday. They issued an "overweight" rating and a $30.00 target price on the stock...
MarketBeat·22d ago
News Placeholder
Aktis Oncology (NASDAQ:AKTS) Earns Outperform Rating from Analysts at Leerink Partners
Leerink Partners assumed coverage on shares of Aktis Oncology in a report on Tuesday. They set an "outperform" rating and a $31.00 price objective on the stock...
MarketBeat·22d ago
News Placeholder
Aktis Oncology (NASDAQ:AKTS) Shares Down 7.1% - Here's What Happened
Aktis Oncology (NASDAQ:AKTS) Stock Price Down 7.1% - Here's Why...
MarketBeat·1mo ago
News Placeholder
Aktis Oncology (NASDAQ:AKTS) Stock Price Up 12.3% - Still a Buy?
Aktis Oncology (NASDAQ:AKTS) Trading 12.3% Higher - Here's What Happened...
MarketBeat·1mo ago
News Placeholder
Aktis Oncology (NASDAQ:AKTS) Reaches New 1-Year Low - Should You Sell?
Aktis Oncology (NASDAQ:AKTS) Sets New 12-Month Low - Should You Sell...
MarketBeat·1mo ago
<
...
1
>

Latest AKTS News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.